https://www.selleckchem.com/pr....oducts/2-deoxy-d-glu
Reactive oxygen species modulator 1 (Romo1) is a key regulator of intracellular reactive oxygen species production. Previous studies have shown that Romo1 overexpression in tumor tissue is associated with poor clinical outcomes in various clinical settings for lung cancer treatment. The aim of the present study was to assess the predictive value of serum Romo1 in patients received curative resection for lung cancer. Serum samples were collected from patients with lung adenocarcinoma who underwent surgical resection. Baseline s